Navi secures $2.3 million CRC-P grant funding

We are delighted to announce Navi has been awarded a Round 14 Cooperative Research Centres Projects (CRC-P) grant to further the development of of the Neonav ECG Tip Location System.

Navi has secured $2.3 million in grant funding as part of a $6.28 million project in collaboration with the University Of Melbourne, the Royal Women’s Hospital, and Design + Industry. The project will support an upcoming pivotal clinical trial to generate data for FDA clearance, and is a major step forward in our journey to bring the Neonav device to market.

The Neonav, which is currently in development, addresses the unmet need for accurate and non-invasive tip location of catheters in critically-ill newborns and children, ultimately enabling clinicians to deliver faster and safer therapies.

Shing Yue Sheung, Navi's Chief Operating Officer, expressed his enthusiasm regarding the CRC-P grant and its potential impact.

“The CRC-P grant funding will play a critical role in advancing our device's path to market, and highlights the hard work and dedication of our entire team. We are immensely grateful to our Project Partners for their support and belief in our vision of helping children live brighter, healthier futures."

The CRC-P grant program supports collaborative research projects that foster innovation and strong partnerships between industry and research organisations, and are awarded through a competitive, merit-based selection process and are assessed by an independent committee of industry experts.

Being awarded this grant not only recognises Navi's potential to improve the standard of care in critically-ill newborn and children, but also acknowledges the collaborative efforts of multiple stakeholders dedicated to advancing medical technologies and improving the lives of our most vulnerable cohort of patients.

On the collaborative nature of the grant, Mr. Sheung continued,

“We would like to acknowledge and thank the Australian Government and it’s CRC-P program for their ongoing commitment and investment in developing the local medtech industry, as well as our Project Partners; The Royal Women's Hospital, the University of Melbourne, and Design + Industry for their continued support.”